Ad
related to: treatment for iga nephropathy- Request a Representative
Learn About a Treatment Option.
Connect With a Representative.
- Mechanism of Action
See the Pathophysiology of IgA
Nephropathy and How it Works.
- Official Patient Website
Visit Our Official Patient Website
for More Information.
- PROTECT Study
Explore The Data.
Learn About the Outcomes.
- Request a Representative
Search results
Results from the WOW.Com Content Network
IgA nephropathy (IgAN), also known as Berger's disease (/ b ɛər ˈ ʒ eɪ /) (and variations), or synpharyngitic glomerulonephritis, is a disease of the kidney (or nephropathy) and the immune system; specifically it is a form of glomerulonephritis or an inflammation of the glomeruli of the kidney.
Sparsentan was approved in the US under accelerated approval based on reduction of proteinuria. [1] [5] [12] In September 2024, the US FDA converted the conditional approval in the kidney disease IgA nephropathy (IgAN) into a full approval based on positive long-term confirmatory results from the PROTECT Study demonstrating that sparsentan significantly slowed kidney function decline over two ...
English: What is IgA nephropathy? IgA nephropathy, sometimes called Berger disease, is a type of nephritic syndrome where abnormal IgA antibody is formed, which results in immune complex deposition in the glomerular mesangium, leading to kidney disease. This video covers the pathophysiology, signs and symptoms, and treatment of IgA nephropathy.
IgA nephropathy is the most common glomerulonephritis throughout the world ... Treatment approaches for kidney disease focus on managing the symptoms, controlling the ...
"Without treatment, chronic kidney disease can lead to end-stage kidney failure, which is fatal without dialysis or a kidney transplant." In the United States, more than 1 in 7 ...
IgA nephropathy, also known as Berger's disease, is the most common type of glomerulonephritis, and generally presents with isolated visible or occult hematuria, occasionally combined with low grade proteinuria, and rarely causes a nephritic syndrome characterised by proteinuria, and visible blood in the urine. IgA nephropathy is classically ...
IgA nephropathy is the most common cause of MesPGN. [3] It is thought abnormally glycosylated IgA form polymers and deposit in the mesangium. [3] Subsequently, IgA immune complexes bind to IgA receptors on mesangial cells and induce injury to mesangial cells through release of cytokines and growth factors that promote infiltration of leukocytes ...
In IgA nephropathy, episodes of frank hematuria are more common, and a family history is less common. A kidney biopsy is the only way to diagnose thin basement membrane disease. It reveals thinning of the glomerular basement membrane from the normal 300 to 400 nanometers (nm) to 150 to 250 nm.
Ad
related to: treatment for iga nephropathy